All In MedTech

Device Trial Radar · NCT06615739

Comprehensive SRS Regenerex Tissue Attachment

PMCF Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive Segmental Revision System (SRS) Regenerex Tissue Attachment Augments - A Retrospective Enrollment and Prospective Follow-up Consecutive Series Study

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

22

Actual

Start

Oct 22, 2024

Primary completion

Feb 26, 2026

Study completion Feb 26, 2026

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Sep 27, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Conditions

  • Arthroplasty Complications
  • Osteo Arthritis Shoulders

Interventions

  • Regenerex Tissue Attachment AugmentsDevice

    Patient will have been previously implanted with Regenerex Tissue Attachment Augments in combination with the Comprehensive Segmental Revision System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Kaplan Meier Implant SurvivorshipTime frame: Up to 10 Years
  2. Safety AssessementTime frame: Up to 10 Years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Toman Orthopedics and Sports Med

    Boca Raton, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.